DILIGAN 12.5 MG TABLET
By Diligan
Rx
10 Tablet in a Strip

Composition
Meclizine(12.5mg)

Manufacturer - Dr Reddy's Laboratories Ltd
Dr. Reddy's Laboratories Ltd., 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500034, INDIA

Expires on or after
September, 2025

liver
Limited information is available regarding the use of DILIGAN 12.5 MG TABLET in individuals with liver disease. It is crucial to consult your healthcare provider before taking this medication if you have any liver-related concerns. Your doctor is the best person to advise you on the appropriate use of DILIGAN 12.5 MG TABLET in relation to your liver health.

kidney
Consult with your doctor for proper guidance before using DILIGAN 12.5 MG TABLET.

alcohol
DILIGAN 12.5 MG TABLET can lead to increased drowsiness when taken with alcohol.

driving
When using DILIGAN 12.5 MG TABLET, be cautious as it may lower alertness, impact vision, and cause drowsiness or dizziness. If experiencing these effects, avoid driving.

pregnancy
DILIGAN 12.5 MG TABLET is usually safe to use during pregnancy, with minimal adverse effects observed in animal studies. Limited human studies are available regarding its safety for the developing baby.

breastfeeding
DILIGAN 12.5 MG TABLET is considered safe during breastfeeding based on limited data, showing no significant risk. However, higher doses or prolonged use may lead to drowsiness and other effects on the baby.
Habit Forming | No |
Chemical Class | Piperazine Derivative |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | H1 Antihistaminics (First Generation) |
₹83.2
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 11-Feb-2025